The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy
Abstract
Background —Idiopathic dilated cardiomyopathy (IDC) frequently is a progressive disease without causative therapy options. Following the hypothesis that in certain patients autoantibodies against cardiac structures may induce, maintain, or promote the progression of the disease, we investigated whether the elimination of these autoantibodies through immunoadsorption would improve cardiac function. Methods and Results —This prospective case-control study included 34 patients with IDC. Each patient presented with moderate to severe heart failure and evidence of autoantibodies directed against β 1 -adrenoceptors (β 1 -AABs). Seventeen patients received standard medical therapy (control group), whereas 17 were also treated with immunoadsorption (treatment group) to eliminate β 1 -AABs. A 1-year follow-up included echocardiographic assessment of left ventricular ejection fraction and internal diameters, β 1 -AAB levels, and clinical status every 3 months. Within 1 year, the mean±SD left ventricular ejection fraction rose from 22.3±3.3% to 37.9±7.9% ( P =0.0001) in the treatment group, with a relative increase of 69.9%. However, in the control group, no overall increase was seen (from 23.8±3.0% to 25.2±5.9%, P =0.3154). Left ventricular diameter in diastole decreased by 14.5% from 74.5±7.1 to 63.7±6.0 mm in the treatment group ( P =0.0001) and by 3.8% ( P =0.2342) in the control group. In the treatment group, the NYHA functional rating improved after immunoadsorption ( P =0.0001). β 1 -AABs did not increase anew. Conclusions —In IDC, the use of immunoadsorption is superior to the use of standard medical therapy. It significantly improves cardiac performance and clinical status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Box, G. E. P. (1954) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177728786 · Cited by 1,513
NON-NORMALITY AND TESTS ON VARIANCES
BOX, G. E. P. (1953) · Biometrika · doi:10.1093/biomet/40.3-4.318 · Cited by 1,302
Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., Gillam, L. D., et al. (1997) · Circulation · doi:10.1161/01.cir.95.6.1686 · Cited by 831
Reichek, N., Wilson, J., St John Sutton, M., Plappert, T. A., Goldberg, S., & Hirshfeld, J. W. (1982) · Circulation · doi:10.1161/01.cir.65.1.99 · Cited by 655
de Simone, G., Devereux, R. B., Roman, M. J., Ganau, A., Saba, P. S., Alderman, M. H., & Laragh, J. H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90390-5 · Cited by 607
Greenberg, B., Quinones, M. A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., & Shelton, B. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Verteilungsfreie Methoden in der Biostatistik
Bortz, J., Lienert, G. A., & Boehnke, K. (1990) · Springer-Lehrbuch · doi:10.1007/978-3-662-22593-6 · Cited by 448
Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune Diseases
Yu, Z., & Lennon, V. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400311 · Cited by 427
Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C., & Levy, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361903 · Cited by 402
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Murphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Szczepiorkowski, Z. M., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Shaz, B. H., Weinstein, R., Wirk, A., et al. (2007) · Journal of Clinical Apheresis · doi:10.1002/jca.20129 · Cited by 546
Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Weinstein, R., & Shaz, B. H. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20240 · Cited by 508
Advances in the Understanding of Myocarditis
Liu, P. P., & Mason, J. W. (2001) · Circulation · doi:10.1161/hc3401.095198 · Cited by 494
Bennett, J. A., Riegel, B., Bittner, V., & Nichols, J. (2002) · Heart & Lung · doi:10.1067/mhl.2002.124554 · Cited by 445
Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., & Lohse, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420149 · Cited by 383
Wallukat, G., Hohberger, B., Wenzel, K., Fürst, J., Schulze-Rothe, S., Wallukat, A., Hönicke, A.-S., & Müller, J. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100100 · Cited by 362
Self-citationInflammatory Cytokines in Heart Failure: Mediators and Markers
Gullestad, L., Ueland, T., Vinge, L. E., Finsen, A., Yndestad, A., & Aukrust, P. (2012) · Cardiology · doi:10.1159/000338166 · Cited by 350
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
Gullestad, L., Aass, H., Fjeld, J. G., Wikeby, L., Andreassen, A. K., Ihlen, H., Simonsen, S., Kjekshus, J., Nitter-Hauge, S., Ueland, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.220 · Cited by 349
Caforio, A. L. P., Mahon, N. J., Tona, F., & McKenna, W. J. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00010-7 · Cited by 273
Immune Activation in Chronic Heart Failure
Torre-Amione, G. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.006 · Cited by 272
Cardiac Autoimmunity: Myocarditis
Bracamonte-Baran, W., & Čiháková, D. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-57613-8_10 · Cited by 228
Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Mitamura, H., & Ogawa, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01109-8 · Cited by 165
Chiale, P. A., Garro, H. A., Schmidberg, J., Sánchez, R. A., Acunzo, R. S., Lago, M., Levy, G., & Levin, M. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.06.011 · Cited by 114
Baba, A., Yoshikawa, T., & Ogawa, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02075-2 · Cited by 92
“The hypothesis that autoimmunity may cause cardiomyopathy is supported by the improvement in subjective symptoms and hemodynamics in patients after the removal of autoantibodies (Abs) by immunoadsorption (8).”
BackgroundThe role of inflammation in the pathogenesis of heart failure
Lisman, K. A., Stetson, S. J., Koerner, M. M., Farmer, J. A., & Torre-Amione, G. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0051-3 · Cited by 18
Metadata
- Authors
- Müller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., Nissen, E., Kunze, R., & Hetzer, R.
- Venue
- Circulation
- Published
- 2000-02
- Volume
- 101
- Issue
- 4
- Pages
- 385-391
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2053831533
- Cited by
- 340
- References
- 27
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.